Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Bostwick

Showing results (121-130 of 317) with videos related to

Pageof 32
Sort By:
Human Pathology|May 22, 1998
Prostatic adenocarcinoma with glomeruloid featuresA Pacelli, A Lopez-Beltran, A J Egan, et al.
The Urologic Clinics of North America|November 1, 1993
PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumorsJ E Oesterling, V J Suman, H Zincke, et al.
Cancer|January 29, 2000
Flat intraepithelial lesions of the urinary bladderL Cheng, J C Cheville, R M Neumann, et al.
Urology|October 8, 1998
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastasesS D Sweat, A Pacelli, G P Murphy, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2000
Prostate-specific antigen as a marker of prostate diseaseR Montironi, R Mazzucchelli, F Algaba, et al.
The Prostate|December 1, 1999
Over-expression of cyclooxygenase-2 in human prostate adenocarcinomaS Gupta, M Srivastava, N Ahmad, et al.
Journal of the National Cancer Institute|November 20, 1996
Comparing the age at prostate cancer diagnosis in humans and dogsD J Waters, G J Patronek, D G Bostwick, et al.
American Journal of Clinical Pathology|October 1, 1984
Gastrin-releasing peptide immunoreactivity in intestinal carcinoidsD G Bostwick, K A Roth, J D Barchas, et al.
Urology|June 1, 1997
A review of clinical and pathological prostatitis syndromesR O Roberts, M M Lieber, D G Bostwick, et al.
The Journal of Urology|May 1, 1995
The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basisM R Cupp, D G Bostwick, R P Myers, et al.
Pageof 32

Showing results (121-130 of 317) with videos related to

Sort By:
Pageof 32
Human Pathology|May 22, 1998
Prostatic adenocarcinoma with glomeruloid featuresA Pacelli, A Lopez-Beltran, A J Egan, et al.
The Urologic Clinics of North America|November 1, 1993
PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumorsJ E Oesterling, V J Suman, H Zincke, et al.
Cancer|January 29, 2000
Flat intraepithelial lesions of the urinary bladderL Cheng, J C Cheville, R M Neumann, et al.
Urology|October 8, 1998
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastasesS D Sweat, A Pacelli, G P Murphy, et al.
Virchows Archiv : an International Journal of Pathology|June 2, 2000
Prostate-specific antigen as a marker of prostate diseaseR Montironi, R Mazzucchelli, F Algaba, et al.
The Prostate|December 1, 1999
Over-expression of cyclooxygenase-2 in human prostate adenocarcinomaS Gupta, M Srivastava, N Ahmad, et al.
Journal of the National Cancer Institute|November 20, 1996
Comparing the age at prostate cancer diagnosis in humans and dogsD J Waters, G J Patronek, D G Bostwick, et al.
American Journal of Clinical Pathology|October 1, 1984
Gastrin-releasing peptide immunoreactivity in intestinal carcinoidsD G Bostwick, K A Roth, J D Barchas, et al.
Urology|June 1, 1997
A review of clinical and pathological prostatitis syndromesR O Roberts, M M Lieber, D G Bostwick, et al.
The Journal of Urology|May 1, 1995
The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basisM R Cupp, D G Bostwick, R P Myers, et al.
Pageof 32